These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27864603)

  • 41. Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma.
    Connors JM; Ansell SM; Fanale M; Park SI; Younes A
    Blood; 2017 Sep; 130(11):1375-1377. PubMed ID: 28733323
    [No Abstract]   [Full Text] [Related]  

  • 42. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    Subbiah V
    N Engl J Med; 2008 Feb; 358(7):743; author reply 743. PubMed ID: 18283721
    [No Abstract]   [Full Text] [Related]  

  • 43. Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90.
    Landman-Parker J; Pacquement H; Leblanc T; Habrand JL; Terrier-Lacombe MJ; Bertrand Y; Perel Y; Robert A; Coze C; Thuret I; Donadieu J; Schaison G; Leverger G; Lemerle J; Oberlin O
    J Clin Oncol; 2000 Apr; 18(7):1500-7. PubMed ID: 10735898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL).
    Zallio F; Tamiazzo S; Monagheddu C; Merli F; Ilariucci F; Stelitano C; Liberati AM; Mannina D; Vitolo U; Angelucci E; Rota Scalabrini D; Vallisa D; Bellei M; Bari A; Ciccone G; Salvi F; Levis A
    Br J Haematol; 2016 Mar; 172(6):879-88. PubMed ID: 26763986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.
    Diehl V; Franklin J; Hasenclever D; Tesch H; Pfreundschuh M; Lathan B; Paulus U; Sieber M; Rueffer JU; Sextro M; Engert A; Wolf J; Hermann R; Holmer L; Stappert-Jahn U; Winnerlein-Trump E; Wulf G; Krause S; Glunz A; von Kalle K; Bischoff H; Haedicke C; Duehmke E; Georgii A; Loeffler M
    J Clin Oncol; 1998 Dec; 16(12):3810-21. PubMed ID: 9850026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The vanishing bile duct syndrome in a child with Hodgkin disease.
    Ozkan A; Yoruk A; Celkan T; Apak H; Yildiz I; Ozbay G
    Med Pediatr Oncol; 2001 Mar; 36(3):398-9. PubMed ID: 11241447
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment of favorable, limited-stage Hodgkin's lymphoma with chemotherapy without consolidation by radiation therapy.
    Canellos GP; Abramson JS; Fisher DC; LaCasce AS
    J Clin Oncol; 2010 Mar; 28(9):1611-5. PubMed ID: 20159818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Consolidation radiotherapy may improve outcomes in people with Hodgkin's disease achieving complete remission after combination chemotherapy.
    Specht L
    Cancer Treat Rev; 2004 Aug; 30(5):479-82. PubMed ID: 15245780
    [No Abstract]   [Full Text] [Related]  

  • 49. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
    Engert A; Diehl V; Franklin J; Lohri A; Dörken B; Ludwig WD; Koch P; Hänel M; Pfreundschuh M; Wilhelm M; Trümper L; Aulitzky WE; Bentz M; Rummel M; Sezer O; Müller-Hermelink HK; Hasenclever D; Löffler M
    J Clin Oncol; 2009 Sep; 27(27):4548-54. PubMed ID: 19704068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of advanced stage Hodgkin lymphoma--it's all about risk-benefit.
    Phipps C; Lee YS; Hwang W
    Br J Haematol; 2012 Oct; 159(1):113-5. PubMed ID: 22823109
    [No Abstract]   [Full Text] [Related]  

  • 51. Increased relapse rates in early stage hodgkin lymphoma (HL) patients without radiotherapy: the German Society of Radiooncology (DEGRO) advises to treat all early stage HL patients with radiotherapy.
    Körholz D; Mauz-Körholz C; Vordermark D; Kluge R; Dieckmann K
    Klin Padiatr; 2014 Nov; 226(6-7):307-8. PubMed ID: 25431863
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease.
    Hirsch A; Vander Els N; Straus DJ; Gomez EG; Leung D; Portlock CS; Yahalom J
    J Clin Oncol; 1996 Apr; 14(4):1297-305. PubMed ID: 8648387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and efficacy of once-per-cycle pegfilgrastim in support of ABVD chemotherapy in patients with Hodgkin lymphoma.
    Younes A; Fayad L; Romaguera J; Pro B; Goy A; Wang M
    Eur J Cancer; 2006 Nov; 42(17):2976-81. PubMed ID: 17008093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS
    J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214
    [No Abstract]   [Full Text] [Related]  

  • 55. Bleomycin-induced Raynaud's phenomenon after single-dose exposure: risk factors and treatment with intravenous iloprost infusion.
    McGrath SE; Webb A; Walker-Bone K
    J Clin Oncol; 2013 Feb; 31(4):e51-2. PubMed ID: 23270004
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy.
    Donaldson SS; Link MP; McDougall IR; Parker BR; Shochat SJ
    Cancer Treat Res; 1989; 41():307-15. PubMed ID: 2484294
    [No Abstract]   [Full Text] [Related]  

  • 57. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease.
    Jost LM; Stahel RA;
    Ann Oncol; 2005; 16 Suppl 1():i54-5. PubMed ID: 15888755
    [No Abstract]   [Full Text] [Related]  

  • 58. Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma.
    Filippi AR; Ciammella P; Piva C; Ragona R; Botto B; Gavarotti P; Merli F; Vitolo U; Iotti C; Ricardi U
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):370-5. PubMed ID: 24613810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy.
    Gandikota N; Hartridge-Lambert S; Migliacci JC; Yahalom J; Portlock CS; Schöder H
    Cancer; 2015 Jun; 121(12):1985-92. PubMed ID: 25739719
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens.
    Rassidakis GZ; Medeiros LJ; Vassilakopoulos TP; Viviani S; Bonfante V; Nadali G; Herling M; Angelopoulou MK; Giardini R; Chilosi M; Kittas C; McDonnell TJ; Bonadonna G; Gianni AM; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
    Blood; 2002 Dec; 100(12):3935-41. PubMed ID: 12433696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.